Zymeworks Inc

NYSE:ZYME   9:58:01 AM EDT
-0.01 (-0.09%)
Products, Strategic Combinations

Zymeworks Inc First Patient Dosed In South Korea Under Zymeworks And Beigene Collaboration Agreement

Published: 12/09/2021 13:54 GMT
Zymeworks Inc (ZYME) - Zymeworks Announces Expansion of Zanidatamab Pivotal Trial in Asia in Collaboration With Beigene and Associated Milestone Payment.
Zymeworks Inc - First Patient Dosed in South Korea Under Zymeworks and Beigene Collaboration Agreement.
Zymeworks Inc - Herizon-gea-01 Enrollment Progresses With Multiple Active Sites and Continued Global Recruitment.
Zymeworks Inc - Zymeworks to Receive Us$8mm Development Milestone Payment From Beigene.